Phosducin - A candidate gene for stress-dependent hypertension

Journal of Clinical Investigation

Volumn 119, Issue 12, 2009, Pages 3515-3518

  Grassi, Guido ^a  

^a SAN GERARDO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSDUCIN; PRAZOSIN;

ADRENERGIC ACTIVITY; BLOOD PRESSURE; CARDIOVASCULAR MALFORMATION; CARDIOVASCULAR RESPONSE; EXPERIMENTAL STUDY; HEREDITY; HUMAN; HYPERTENSION; NONHUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; STRESS; SYMPATHETIC FUNCTION;

ANIMALS; BLOOD PRESSURE; EPINEPHRINE; EYE PROTEINS; GTP-BINDING PROTEIN REGULATORS; HUMANS; HYPERTENSION; MICE; MODELS, CARDIOVASCULAR; NEUROSECRETORY SYSTEMS; PHOSPHOPROTEINS; STRESS, PHYSIOLOGICAL; SYMPATHETIC NERVOUS SYSTEM;

EID: 72849150933     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI41508     Document Type: Note

References (24)

1. Beetz, N., et al. 2009. Phosducin influences sympathetic activity and prevents stress-induced hypertension in humans and mice. J. Clin. Invest. 119:3597-3612.
2. Cannon, W.B. 1929. Bodily changes in pain, hunger, fear and rage. D. Appleton & Company. New York, New York, USA. 404 pp.
3. Folkow, B., Heymans, C., and Neil, E. 1965. Integrated aspects of cardiovascular regulation. In Handbook of physiology. Section 2, Volume 3. W.F. Hamilton and P. Dow, editors. American Physiology Society. Washington, DC, USA. 1787-1823.
4. Adams, D.B., Baccelli, G., Mancia, G., and Zanchetti, A. 1968. Cardiovascular changes during preparation for fighting behaviour in the cat. Nature. 220:1239-1240.
5. Mancia, G., Baccelli, G., and Zanchetti, A. 1972. Haemodynamic responses to different emotional stimuli in the cat: patterns and mechanisms. Am. J. Physiol. 223:925-933.
6. Brod, J., Frencl, V., Heiz, Z., and Jirka, J. 1958. Circulatory changes underlying blood pressure elevation during acute emotional stress (mental arithmetic) in normotensive and hypertensive subjects. Clin. Sci. 18:269-279.
7. Mancia, G., and Parati, G. 1987. Reactivity to physical and behavioral stress and blood pressure variability in hypertension. In Handbook of hypertension. S. Julius and D.R. Basset, editors. Elsevier. Amsterdam, The Netherlands. 104-122.
8. Parati, G., et al. 1988. Comparison of the cardiovascular effects of different laboratory stressors and their relationship with blood pressure variability. J. Hypertens. 6:481-488. (Pubitemid 18178889)
9. Wood, D.L., Sheps, S.G., Elveback, L.R., and Schirger, A. 1984. Cold pressor test as a predictor of hypertension. Hypertension. 6:301-306. (Pubitemid 14091456)
10. Matthews, K.A., Woodall, K.L., and Allen, M.T. 1993. Cardiovascular reactivity to stress predicts future blood pressure status. Hypertension. 22:479-485.
11. Cowley, A.W., Jr. 2006. The genetic dissection of essential hypertension. Nat. Rev. Genet. 7:829-840.
12. Mancia, G., et al. 2007. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 25:1105-1187. (Pubitemid 46924065)
13. Schulz, R. 2001. The pharmacology of Phosducin. Pharmacol. Res. 43:1-9.
14. Ara-Iwata, F., et al. 1996. Analysis of phosducin as a candidate gene for retinopathies. Ophthalmic Genet. 17:3-14. (Pubitemid 26134989)
15. Nishiguchi, K.M., et al. 2004. Mutation screening of phosducin gene PDC in patients with retinitis pigmentosa and allied diseases. Mol. Vis. 10:62-64.
16. Partridge, J.G., et al. 2006. Phosducin and Phosducin-like protein attenuate G-protein-coupled receptor-mediated inhibition of voltage-gated calcium channels in rat sympathetic neurons. Mol. Pharmacol. 70:90-100.
17. Grassi, G., et al. 2009. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension. 54:690-697.
18. Grassi, G., et al. 1998. Heart rate as marker of sympathetic activity. J. Hypertens. 16:1635-1639. (Pubitemid 28515490)
19. Grassi, G. 2008. Heart rate as a sympathetic marker during acute adrenergic challenge. J. Hypertens. 26:70-75. (Pubitemid 350294851)
20. Greenfield, J.R., et al. 2009. Modulation of blood pressure by central melanocortinergic pathways. N. Engl. J. Med. 360:44-52.
21. Zhou, Z., et al. 2008. Genetic variation in human NPY expression affects stress response and emotion. Nature. 452:997-1001. (Pubitemid 351589618)
22. Wang, L., et al. 2009. Neuropeptide Y(1) Receptor NPY1R discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo. J. Am. Coll. Cardiol. 54:944-954.
23. Zhao, Q., et al. 2007. Renalase gene is a novel susceptibility gene for essential hypertension: a twostage association study in northern Han Chinese population. J. Mol. Med. 85:877-885. (Pubitemid 47077106)
24. Grassi, G., et al. 2009. Association between alpha- 1A-adrenoreceptor gene polymorphism and sympathetic activation in patients with the metabolic syndrome. J. Hypertens. 27(Suppl. 4):S164.